Sanofi India (SANOFI)
SLOW GROWERFairStock Score: 21/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 1/1
Key Financials
| Current Price | ₹3,445.3 |
| Market Cap | ₹9,131.63 Cr |
| P/E Ratio | 26.36 |
| ROCE | 57.53% |
| ROE | 37.96% |
| Dividend Yield | 2.95% |
| Profit Growth | -27.68% |
| Debt/Equity | 0.02 |
| Sales Growth | -18.47% |
| Free Cash Flow | ₹3,58,27,49,952 Cr |
| Promoter Holding | 60.4% |
| 52-Week Range | ₹3,054 — ₹6,410 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹373.96 |
Sanofi India trades with a P/E ratio of 26.36, ROCE of 57.53%, ROE of 37.96%, profit growth of -27.68%, debt-to-equity of 0.02. The FairStock Score of 21/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer